A composition,
system, articles and method for the enhancement of clotting in wounds with extravascular
blood flow, especially where the surface of the tissue has been broken is described. The
system consists of biotolerable, porous
particulates applied to the surface of a wound with liquid blood thereon. The porous nature of the
particulate material, either free-flowing or packaged or restrained on or in a surface, enhances clotting. Chemical or biochemical agents, such as additional clotting agents, therapeutic agents,
antibiotics, clot strengthening agents (such as fibrous structural materials), and the like may optionally be included on, with or within the porous particles. The particles may comprise such diverse materials as organics, metallics, inorganics, ceramics, and the like, both natural and artificial. It is generally preferred that the pore size distribution lies within a general range, and this range may vary from animal to animal and condition to condition, but generally falls within about 0.5 to 1000 nanometers or 3,000 to 200,000 Daltons.